Molecular Partners (MOLN) Expected to Announce Quarterly Earnings on Thursday

Molecular Partners (NASDAQ:MOLN) is anticipated to release its earnings data before the market opens on Thursday, March 6th. Analysts expect Molecular Partners to post earnings of ($0.45) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Molecular Partners Price Performance

Shares of MOLN stock opened at $5.03 on Friday. The firm has a market cap of $203.03 million, a PE ratio of -2.34 and a beta of 1.06. The company has a 50-day moving average of $5.16 and a two-hundred day moving average of $5.43. Molecular Partners has a 1-year low of $3.32 and a 1-year high of $12.70.

Molecular Partners Company Profile

Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia.